AcquisitionOther
Aditxt, Inc. acquired MDNA Life Sciences Inc.'s Proprietary Mitomic&trade
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Aditxt, Inc. -> MDNA Life Sciences Inc.'s Proprietary Mitomic&trade · $25 Million
Acquires MDNA Life Sciences Inc.'s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million This strategic acquisition positions Pearsanta for robust growth: expanding opport
Open source record (SEC) ↗